Six-Month Patient-Reported Outcome (Pro) Results From Aquarius, A Prospective, Observational, Multicenter Phase 4 Study In Patients (Pts) With Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Receiving Abiraterone Acetate Plus Prednisone (Aap) Or Enzalutamide (Enz).

JOURNAL OF CLINICAL ONCOLOGY(2018)

引用 6|浏览18
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要